Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qifeng Yang

Showing results (191-200 of 324) with videos related to

Pageof 33
Sort By:
Cancer Treatment Reviews|October 19, 2020
Special subtypes with favorable prognosis in breast cancer: A registry-based cohort study and network meta-analysisHanwen Zhang, Ning Zhang, Meena S Moran, et al.
Carcinogenesis|October 3, 2012
53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-κB through miR-146aXiaoyan Li, Bing Xu, Meena S Moran, et al.
International Journal of Biological Sciences|January 5, 2013
Inhibition of filamin-A reduces cancer metastatic potentialXi Jiang, Jingyin Yue, Huimei Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|August 6, 2013
Is Ki-67 expression prognostic for local relapse in early-stage breast cancer patients treated with breast conservation therapy (BCT)?Farhaan Hafeez, Hanmanth J Neboori, Malini Harigopal, et al.
Cancer Science|March 5, 2011
Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transitionXiaoyan Li, Xiaoli Kong, Qiang Huo, et al.
Anticancer Research|January 18, 2003
5-aza-2'-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cellsQifeng Yang, Liang Shan, Goro Yoshimura, et al.
Anticancer Research|August 10, 2002
Correlation of prostate-specific antigen promoter polymorphisms with clinicopathological characteristics in breast cancerQifeng Yang, Misa Nakamura, Yasushi Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancerQifeng Yang, Misa Nakamura, Yasushi Nakamura, et al.
Cellular Signalling|January 14, 2020
LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancerTingting Ma, Yiran Liang, Yaming Li, et al.
Journal of Crohn'S & Colitis|May 14, 2021
MTDH Promotes Intestinal Inflammation by Positively Regulating TLR SignallingLijuan Wang, Ning Zhang, Dianwen Han, et al.
Pageof 33

Showing results (191-200 of 324) with videos related to

Sort By:
Pageof 33
Cancer Treatment Reviews|October 19, 2020
Special subtypes with favorable prognosis in breast cancer: A registry-based cohort study and network meta-analysisHanwen Zhang, Ning Zhang, Meena S Moran, et al.
Carcinogenesis|October 3, 2012
53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-κB through miR-146aXiaoyan Li, Bing Xu, Meena S Moran, et al.
International Journal of Biological Sciences|January 5, 2013
Inhibition of filamin-A reduces cancer metastatic potentialXi Jiang, Jingyin Yue, Huimei Lu, et al.
International Journal of Radiation Oncology, Biology, Physics|August 6, 2013
Is Ki-67 expression prognostic for local relapse in early-stage breast cancer patients treated with breast conservation therapy (BCT)?Farhaan Hafeez, Hanmanth J Neboori, Malini Harigopal, et al.
Cancer Science|March 5, 2011
Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transitionXiaoyan Li, Xiaoli Kong, Qiang Huo, et al.
Anticancer Research|January 18, 2003
5-aza-2'-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cellsQifeng Yang, Liang Shan, Goro Yoshimura, et al.
Anticancer Research|August 10, 2002
Correlation of prostate-specific antigen promoter polymorphisms with clinicopathological characteristics in breast cancerQifeng Yang, Misa Nakamura, Yasushi Nakamura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancerQifeng Yang, Misa Nakamura, Yasushi Nakamura, et al.
Cellular Signalling|January 14, 2020
LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancerTingting Ma, Yiran Liang, Yaming Li, et al.
Journal of Crohn'S & Colitis|May 14, 2021
MTDH Promotes Intestinal Inflammation by Positively Regulating TLR SignallingLijuan Wang, Ning Zhang, Dianwen Han, et al.
Pageof 33